Sponsor Pipeline

Sinovac (Dalian) Vaccine Technology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
1
Recruiting
3
Phase 3
Active Trials by Phase
Phase 4
3
Phase 3
3
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT05095701 An Immunity Persistence Study of Live Attenuated Varicella Vaccine Varicella Enrolling by Invitation
NCT06484686 An Immunity Persistence Study of Booster Dose of Live Attenuated Varicella Vaccine Varicella Enrolling by Invitation
NCT06891872 Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP… Varicella (chickenpox) Not Yet Recruiting
Phase 3
NCT07475000 Second Dose of Varicella Vaccine in Healthy Children Varicella (Chickenpox) Recruiting
NCT05015686 Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged… Varicella Enrolling by Invitation
NCT07473427 Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Vietnamese Children Varicella (Chickenpox) Not Yet Recruiting
Not specified
NCT06482216 Correlation of Protection Against Varicella in an Exploratory Study Varicella Not Yet Recruiting
Get alerts when Sinovac (Dalian) Vaccine Technology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free